<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01790009</url>
  </required_header>
  <id_info>
    <org_study_id>FLAV-AGE01</org_study_id>
    <nct_id>NCT01790009</nct_id>
  </id_info>
  <brief_title>Influence of Age on the Absorption and Metabolism of Cocoa Flavanols</brief_title>
  <official_title>Influence of Age on the Absorption and Metabolism of Cocoa Flavanols</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Reading</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Reading</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Accumulating evidence suggests that regular consumption of foods and beverages rich in
      flavanols, such as cocoa, tea, apples and wine, may have cardiovascular benefits. Several
      well-controlled randomised human intervention studies have shown that cocoa flavanols have
      beneficial effects on blood pressure, endothelial function and other biomarkers of
      cardiovascular health. These vascular improvements have been correlated in time with changes
      in plasma flavanol metabolites. The health benefits of flavanol consumption are therefore
      likely dependent on changes in their absorption, distribution, metabolism and excretion
      (ADME). Recent studies have provided detailed information regarding the absorption and
      metabolism of cocoa flavanols. However, there is a lack of information on whether there are
      changes in flavanol absorption and metabolism with increasing age.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma and urine flavanol metabolites</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Paracetamol and methylxanthine plasma and urine levels</measure>
    <time_frame>24 h</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Flavanol Rich drink</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Flavanol-rich drink containing 800 mg/75 Kg of Body Weight (BW)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flavanol rich drink</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Flavanol Intervention drink 400 mg/75 Kg BW</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 tabletsx500 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Flavanol rich drink</intervention_name>
    <arm_group_label>Flavanol Rich drink</arm_group_label>
    <arm_group_label>Flavanol rich drink</arm_group_label>
    <other_name>Comparison of two different doses of a flavanol rich drink</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>2x500 mg Acetaminophen</description>
    <arm_group_label>Acetaminophen</arm_group_label>
    <other_name>Paracetamol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  signed consent form

          -  Caucasian

          -  Good general health

          -  No allergy to milk products or sensitivity to alkaloids/caffeine,

          -  No gastrointestinal disorders (e.g., chronic constipation, diarrhoea, inflammatory
             bowel disease, irritable bowel syndrome, or other chronic gastrointestinal complaints)

          -  Not diabetic or suffering from hypertension (140/90 mm Hg),

          -  No anaemia or gall bladder problems.

        Exclusion Criteria:

          -  those on a weight reducing dietary regimen

          -  Taking any dietary supplements

          -  Consuming more than 15 units (120g) of alcohol per week

          -  Taking anti-inflammatory medication

          -  Smokers

          -  Those with sensitivities to chocolate, reduced calorie sweeteners, dairy, nuts or
             gluten,

          -  Vegetarians or vegans.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeremy Spencer, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Reading</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Food and Nutritional Sciences</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <zip>RG6 6AP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2013</study_first_submitted>
  <study_first_submitted_qc>February 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2013</study_first_posted>
  <last_update_submitted>February 8, 2013</last_update_submitted>
  <last_update_submitted_qc>February 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Reading</investigator_affiliation>
    <investigator_full_name>Jeremy Paul Edward Spencer</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>ADME</keyword>
  <keyword>Flavanols</keyword>
  <keyword>Age</keyword>
  <keyword>Pharmacokinetics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

